Comparison of the Soluble Basal Insulin Analog Insulin Detemir With NPH Insulin | Zendy

Kjeld Hermansen | Zendy; Sten Madsbad | Zendy; Hans Perrild | Zendy; Allan Kristensen | Zendy; Mads Axelsen | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Comparison of the Soluble Basal Insulin Analog Insulin Detemir With NPH Insulin

Author(s) -

Kjeld Hermansen,

Sten Madsbad,

Hans Perrild,

Allan Kristensen,

Mads Axelsen

Publication year - 2001

Publication title -

diabetes care

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 6.636

H-Index - 363

eISSN - 1935-5548

pISSN - 0149-5992

DOI - 10.2337/diacare.24.2.296

Subject(s) - insulin detemir , nph insulin , medicine , insulin , endocrinology , hypoglycemia , glycemic , diabetes mellitus , basal (medicine) , type 2 diabetes , insulin glargine

Insulin detemir (NN304) is a soluble basal insulin analog developed to cover basal insulin requirements. This trial aimed to compare the blood glucose-lowering effect of insulin detemir with that of NPH insulin (NPH) and to evaluate the two treatments with regard to intrasubject variation of fasting blood glucose, incidence of hypoglycemia, dose requirements, and safety.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research